The Patent Cliff is Coming: Are You Ready?
As the pharmaceutical industry navigates a rapidly changing landscape, one constant remains: the expiration of blockbuster patents. With billions of dollars in revenue at stake, strategic planning is more cruc…
Patent Expiration Calendar: Strategic Planning Guide for Pharma Executives Read Post »
"The Patent Puzzle: As AI Takes Center Stage in Drug Discovery, Who Will Own the Breakthroughs?
The intersection of artificial intelligence and pharmaceutical innovation is poised to revolutionize the way we develop life-saving medicines. But as A…
AI Meets Drug Discovery – But Who Gets the Patent? Read Post »
"Breaking Down Barriers: How Mutual Recognition Agreements Can Revolutionize Generic Drug Approvals
In a major shift towards increased efficiency and reduced costs, the pharmaceutical industry is turning to a little-known strategy to fast-track ge…
Leveraging Mutual Recognition Agreements MRA to Fast-Track Generic Drug Approvals Read Post »
"The $1 Trillion Question: Can Specialty Generics Bridge the Gap in Access to Life-Changing Medications?
As the pharmaceutical industry grapples with a looming patent cliff and skyrocketing costs, a quiet revolution is underway. Specialty generics…
The Growing Importance of Specialty Generics in the Pharmaceutical Market Read Post »
"Patent Protection: The Secret Sauce Behind Precision Medicine’s Success Stories
As the precision medicine revolution continues to reshape the pharmaceutical landscape, one often-overlooked factor stands between market leaders and their competitor…
"The Dark Art of Replication: How Generic Drug Makers Are Cracking the Code on Precision and Reproducibility
As the pharmaceutical industry grapples with the complexities of generic drug development, a new wave of innovators is emerging – those wh…
Precision and Reproducibility in Generic Drug Reverse Engineering Read Post »
"The Future of Pharma is Written in Code: Can AI-Designed Medicines Be Owned?
As the lines between human ingenuity and artificial intelligence continue to blur, a new frontier in pharmaceutical innovation has emerged: generative AI-designed drugs….
Generative AI Can Design Drugs. But Can It Own Them? Read Post »
"The Prescription for Change: Canada’s Patent Linkage System Takes Effect
As of today, a landmark policy shift is poised to reshape the pharmaceutical landscape in Canada. The country’s long-awaited Patent Linkage System has officially come into f…
"The Dragon’s Rise: How China’s Pharmaceutical Industry is Igniting a Global Revolution
As the world’s pharmaceutical landscape continues to shift, one nation is emerging as a force to be reckoned with: China. With a projected market value of $1.5…
"The Quiet Takeover of the Pharmacy Industry: How PBMs Are Redefining Their Role and Raising Questions About Transparency and Patient Care
As the pharmacy benefits manager (PBM) landscape continues to evolve, a subtle yet significant shift is unde…
Get new actionable insights and updates from BiotechBlog
